Pancreatic Cancer Research

ResearcherAzienda Ospedaliera Sant'AndreaActive in the last 2 years

Niccolò Petrucciani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4639-5613; OpenAlex author ID A5072459292. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 3 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 14

  1. Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort Co-author DOI 10.3390/onco5040044↗
  2. Oncological Outcome After Laparoscopic 'No-touch' RAMPS Versus 'Touch' Left Pancreatectomy for Pancreatic Adenocarcinoma. Co-author DOI 10.21873/anticanres.16697↗
  3. Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-021-05190-z↗
  4. Neoadjuvant therapy for pancreatic cancer. Last author DOI 10.1007/s13304-021-01186-1↗
  5. Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-020-04697-1↗
  6. Corrigendum to "Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancrea… First author DOI 10.1016/j.ijsu.2019.05.015↗
  7. Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcin… Co-author DOI 10.1097/sla.0000000000003372↗
  8. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral uni… First author DOI 10.1016/j.ijsu.2018.05.025↗
  9. Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis. Co-author DOI 10.1007/s12032-017-0951-0↗
  10. Borderline resectable pancreatic cancer: an evolving concept. Co-author DOI 10.1093/annonc/mdx255↗
  11. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. Co-author DOI 10.1186/s12893-017-0311-1↗
  12. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials. Co-author DOI 10.1007/s12032-016-0742-z↗
  13. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients. Co-author DOI 10.1245/s10434-016-5123-5↗
  14. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph… Co-author DOI 10.1016/j.pan.2014.05.794↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Giovanni Ramacciato · 12 shared papers, 2014–2025 · strength 1.11
  2. Giuseppe R. Nigri · 10 shared papers, 2014–2025 · strength 0.91
  3. Laura Antolino · 6 shared papers, 2016–2025 · strength 0.72
  4. Francesco D’Angelo · 5 shared papers, 2016–2025 · strength 0.57
  5. Jean GUGENHEIM MD3 · 2 shared papers, 2017–2022 · strength 0.34
  6. Elio Jovine · 4 shared papers, 2016–2019 · strength 0.26
  7. Francesco Minni · 4 shared papers, 2016–2019 · strength 0.26
  8. Niccolò Napoli · 4 shared papers, 2016–2019 · strength 0.26
  9. Ugo Boggi · 4 shared papers, 2016–2019 · strength 0.26
  10. Antonio Daniele Pinna · 4 shared papers, 2016–2019 · strength 0.26
  11. Germana de Nucci · 1 shared paper, 2025 · strength 0.21
  12. Gianpiero Manes · 1 shared paper, 2025 · strength 0.21
  13. Alessandro Dario Mazzotta · 1 shared paper, 2023 · strength 0.17
  14. Olivier Soubrane · 1 shared paper, 2023 · strength 0.17
  15. Marc G. Besselink · 1 shared paper, 2023 · strength 0.17
  16. Gianpaolo Balzano · 2 shared papers, 2018–2019 · strength 0.15
  17. Vincenzo Ziparo · 1 shared paper, 2014 · strength 0.04
  18. Genoveffa Balducci Md · 1 shared paper, 2014 · strength 0.04
  19. Marco La Torre · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.